BioChipNet - The informational website on BioChip Technologies

Key U.S. Patent Issues on Expression Pathology’s Liquid Tissue® Technology

Wed, 07 Jan 2009 17:01:18 +0100

Teaser:

Expression Pathology Inc. (EPI) announced today that the U.S. Patent and Trademark Office has issued patent number 7,473,532, which covers methods for preparing tissue for protein analysis, including EPI’s proprietary Liquid Tissue® sample preparation methodology. The claims of the patent are directed to methods that enable discovery and measurement of protein biomarkers in formalin-fixed paraffin-embedded (FFPE) tissue.

Rapid Fertility Testing with Randox Biochips

Tue, 06 Jan 2009 10:52:00 +0100

Teaser:

Crumlin, UK, 06 January 2009 - Randox biochips offer rapid and accurate diagnosis of disorders associated with the reproductive system. The fertility biochip array allows simultaneous quantitative measurement of six fertility hormones from a single patient sample.

Last 2008 BioChipNet Newsletter on Microarray Technology

Tue, 30 Dec 2008 17:23:41 +0100

Dear Readers:

As the end of the year quickly approaches, we bring you the final developments in microarray technology and research. The final newsletter combines information from the months of November and December as a last treat before the end of 2008.

Ariadne Provides Pathway Studio® Interoperability with Illumina’s New GenomeStudio Softwar

Tue, 30 Dec 2008 17:17:58 +0100

Teaser:

Ariadne announces the completion of a key partner program with Illumina Inc., to provide advanced integration and interpretation capabilities for data generated from their iScan and BeadArray Reader platforms. The coupling of Ariadne’s Pathway Studio® to Illumina’s next generation software, GenomeStudio™ Data Analysis Software, provides researchers with a state-of-the-art toolset to quickly analyze expression data for physiological changes, cell signaling and other significant biological changes.

Beckman Coulter Announces FDA Clearance of UniCel® DxH 800

Tue, 23 Dec 2008 21:46:22 +0100

Teaser:

Beckman Coulter, Inc. (NYSE:BEC), a leading developer, manufacturer and marketer of products that simplify and automate complex biomedical testing, ushers in a new era of cellular analysis with the release of the UniCel® DxH 800 Coulter® Cellular Analysis System.

Epigenomics AG and Philips Collaborate on Integrated Automation Solutions for DNA Methylation-based Cancer Diagnostics

Mon, 22 Dec 2008 10:32:08 +0100

Teaser:

Epigenomics AG (Frankfurt Prime Standard: ECX; ISIN: DE000A0BVT96) and Royal Philips Electronics (NYSE: PHG, AEX: PHI) today entered into a collaboration and licensing agreement focusing on novel technologies and methods targeted at the diagnosis of various cancers.

Appointment of Alexandre Mérieux by the bioMérieux Board of Directors

Mon, 22 Dec 2008 10:30:40 +0100

Teaser:

At the meeting of the bioMérieux Board of Directors held on December 19, 2008, Alexandre Mérieux was appointed as “Directeur Général Délégué” of the Company. Stéphane Bancel continues to be responsible for all functions in his role as Chief Executive Officer and to chair the bioMérieux Management Committee.

Illumina Appoints Mark Lewis Senior Vice President of Development

Mon, 15 Dec 2008 14:57:55 +0100

Teaser:

Illumina, Inc. (NASDAQ:ILMN) today appointed Mark Lewis as Senior Vice President of Development. In this newly created role, Mark is responsible for overseeing Illumina’s global product development efforts and will report to Joel McComb, Senior Vice President and General Manager of Illumina’s Life Sciences Business.

Illumina Added to NASDAQ-100 Index

Mon, 15 Dec 2008 14:55:40 +0100

Teaser:

Illumina, Inc. (NASDAQ:ILMN) today announced that the Company was added to the NASDAQ-100 Index(R), effective at the start of trading Monday, December 22, 2008.

Source: Illumina

Agilent Technologies Renews Appointment of Institut de Cancérologie Gustave Roussy as Certified Service Provider for CGH, Gene Expression, MicroRNA Microarrays

Sat, 13 Dec 2008 17:21:03 +0100

Teaser:

Agilent Technologies Inc. (NYSE: A) today announced that the Institut de cancerologie Gustave Roussy (IGR) Genomic Center has renewed its status as an Agilent Certified Service Provider and Reference Training Centre for a broad panel of microarray technologies including comparative genomic hybridisation (CGH), one-colour and dual-colour gene expression, and microRNA profiling.

Ania Mitan is new Executive Vice President Commercial at SIRS-Lab

Thu, 11 Dec 2008 13:15:37 +0100

Teaser:

SIRS-Lab is pleased to announce the appointment of Ania Mitan as Executive Vice President Commercial. This expansion of the senior management accelerates the routine implementation of SIRS-Lab’s breakthrough diagnostic suite for sepsis. In her capacity, Ania Mitan will be responsible for commercial planning and execution as well as business development.

Micralyne, a world-leading, independent MEMS Manufacturer, Appoints David Buckley as Vice President of Product Line Management, Sales and Marketing

Mon, 08 Dec 2008 16:25:16 +0100

Teaser:

Micralyne Inc, a successful Canadian MEMS Manufacturer, has recently announced the appointment of Dr. David Buckley as Vice President of Product Line Management (PLM).

Affymetrix Completes Acquisition of Panomics

Mon, 08 Dec 2008 15:59:35 +0100

Teaser:

Affymetrix, Inc. (Nasdaq:AFFX) today announced the completion of its acquisition of Panomics, Inc., a privately held, Fremont, Calif.-based company which offers a powerful suite of assay products for a wide variety of low- to mid-plex genetic, protein, and cellular analysis applications.

Lumera Corporation Announces Shareholder Approval of GigOptix Merger

Fri, 05 Dec 2008 16:30:07 +0100

Teaser:

Lumera Corporation (NASDAQ: LMRA), announced today that its merger with GigOptix LLC was approved by its stockholders at the annual meeting of stockholders held this morning. The closing of the merger is expected to occur on December 9 and the new combined entity will be called GigOptix, Inc. All proxy proposals were voted in favor by at least 54 percent of the total outstanding shares of Lumera’s common stock.

Rosetta Biosoftware Releases the Rosetta Elucidator® System Version 3.2

Thu, 04 Dec 2008 16:31:01 +0100

Teaser:

Rosetta Biosoftware, a global leader in life sciences informatics solutions, today announced the availability of the Elucidator system version 3.2, with major enhancements for support of SILAC and 14N/15N labeling and phosphoproteomics. The expanded suite of features empowers scientists with new workflows for biomarker discovery, verification and validation in basic and translational research.